Portrait of Prof Olivier Piguet

Frontier

CLINIC INFORMATION

About

FRONTIER is a clinical research group in Sydney, Australia dedicated to the study of frontotemporal dementia (FTD) and related disorders, notably motor neurone disease (Amyotrophic Lateral Sclerosis).

The members of FRONTIER are investigating the cognitive, behavioural, psychological, and brain changes associated with this disease and the impact on patients and their families. They are also studying how changes in FTD differ from those seen in other progressive neurodegenerative brain disorders, and in healthy aging. This research group is led by Professor John Hodges and Dr Olivier Piguet, who together with their team collaborate with clinicians, scientists and other researchers across Australia and overseas.

The goals of FRONTIER are:

  • To understand the effects of FTD on brain structures and brain functions;
  • To improve methods of diagnosis;
  • To assist individuals with FTD and their families.

FRONTIER is based at Neuroscience Research Australia (NeuRA), which is part of the University of New South Wales Brain Research Precinct.

See what’s going on at NeuRA

FEEL THE BUZZ IN THE AIR? US TOO.

'I've got the best job for you dad. Your shaky arm will be perfect for it!'

Children… honest and insightful. Their innocence warms the heart. But what words do you use to explain to a child that daddy has an incurable brain disease? What words tell them that in time he may not be able to play football in the park, let alone feed himself? What words help them understand that in the later stages, dementia may also strike? Aged just 36, this was the reality that faced Steve Hartley. Parkinson's disease didn't care he was a fit, healthy, a young dad and devoted husband. It also didn't seem to care his family had no history of it. The key to defeating Parkinson's disease is early intervention, and thanks to a global research team, led by NeuRA, we're pleased to announce that early intervention may be possible. Your support, alongside national and international foundations Shake it Up Australia and the Michael J Fox Foundation, researchers have discovered that a special protein, found in people with a family history of the disease increases prior to Parkinson’s symptoms developing. This is an incredible step forward, because it means that drug therapies, aimed at blocking the increase in the protein, can be administered much earlier – even before symptoms strike. The next step is to understand when to give the drug therapies and which people will most benefit from it. But we need your help. A gift today will support vital research and in time help medical professionals around the world treat Parkinson’s disease sooner, with much better health outcomes. Thank you, in advance, for your support.  
APPEAL